SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-071893
Filing Date
2013-09-24
Accepted
2013-09-24 16:21:01
Documents
4
Period of Report
2013-09-18
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-21207_18k.htm 8-K 38689
2 EX-3.1 a13-21207_1ex3d1.htm EX-3.1 45237
3 EX-3.2 a13-21207_1ex3d2.htm EX-3.2 99474
4 EX-10.1 a13-21207_1ex10d1.htm EX-10.1 72198
  Complete submission text file 0001104659-13-071893.txt   256984
Mailing Address 128 SYDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SYDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Filer) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36065 | Film No.: 131112493
SIC: 2836 Biological Products, (No Diagnostic Substances)